株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

マイクロフルイディクスの世界市場 - 2021年までの予測:マイクロ流体チップ、マイクロポンプ、マイクロニードル

Microfluidics Market by Component (Microfluidic Chips, Micropump, Microneedle), Material (Polymer, Glass, Silicon), Application (Genomics, Proteomics, Capillary Electrophoresis, POC, Clinical, Environmental, Drug Delivery) - Global Forecast to 2021

発行 MarketsandMarkets 商品コード 292250
出版日 ページ情報 英文 207 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。
Back to Top
マイクロフルイディクスの世界市場 - 2021年までの予測:マイクロ流体チップ、マイクロポンプ、マイクロニードル Microfluidics Market by Component (Microfluidic Chips, Micropump, Microneedle), Material (Polymer, Glass, Silicon), Application (Genomics, Proteomics, Capillary Electrophoresis, POC, Clinical, Environmental, Drug Delivery) - Global Forecast to 2021
出版日: 2016年12月06日 ページ情報: 英文 207 Pages
概要

世界のマイクロフルイディクス (マイクロ流体工学) 市場は、2016年の36億5000万米ドルから、2021年までに87億8000万米ドルまで拡大すると見られています。市場は、2016年〜2021年のCAGR (複合年間成長率) で、19.2%の成長が予測されています。

当レポートでは、世界のマイクロフルイディクス市場について調査分析し、市場概要、産業動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • マイクロフルイディクス市場の成長可能性
  • アジア太平洋地域のマイクロフルイディクス市場:材料別
  • マイクロフルイディクス市場:地域別の成長機会
  • 北米がマイクロフルイディクス市場で優勢
  • マイクロフルイディクス市場:途上国 vs. 先進国
  • マイクロフルイディクス市場:用途別

第5章 マイクロフルイディクスの世界市場:概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題

第6章 マイクロフルイディクスの世界市場:産業動向

  • イントロダクション
  • バリューチェーン分析
  • 産業動向

第7章 マイクロフルイディクスの世界市場:コンポーネント別

  • イントロダクション
  • マイクロ流体チップ
  • マイクロポンプ
  • マイクロニードル
  • その他

第8章 マイクロフルイディクスの世界市場:材料別

  • イントロダクション
  • ポリマー
  • ガラス
  • シリコン
  • その他

第9章 マイクロフルイディクスの世界市場:用途別

  • イントロダクション
  • 体外診断 (IVD)
  • 医薬品研究
  • ドラッグデリバリー

第10章 マイクロフルイディクスの世界市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第11章 競合情勢

  • 概要
  • 競合状況と動向

第12章 企業プロファイル

  • イントロダクション
  • DANAHER CORPORATION
  • THERMO FISHER SCIENTIFIC INC.
  • PERKINELMER, INC.
  • AGILENT TECHNOLOGIES
  • BIO-RAD LABORATORIES, INC.
  • BECTON, DICKINSON AND COMPANY
  • F. HOFFMANN-LA ROCHE LTD.
  • ILLUMINA, INC.
  • RAINDANCE TECHNOLOGIES, INC.
  • DOLOMITE MICROFLUIDICS

第13章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MD 4809

Over the past five years, the microfluidics market has witnessed tremendous growth primarily due to rising demand for point-of-care (POC) testing, increasing use of miniaturized microfluidic chips to achieve faster testing and improved portability, and increased prevalence of age-related and lifestyle diseases and disorders.

The global microfluidics market is projected to reach USD 8.78 billion by 2021 from USD 3.65 billion in 2016, growing at a CAGR of 19.2% during the forecast period. The market is mainly driven by the rising geriatric population, growing Asian healthcare market, and upsurge in government and corporate funding for R&D. However, lack of adequate healthcare and research infrastructure in emerging markets, dearth of skilled professionals in clinical laboratories, and high prices of integrated instruments and microfluidics chips are hampering the growth of this market to a certain extent.

In this report, the global microfluidics market is segmented on the basis of component materials and applications. On the basis of component, the market is segmented into microfluidic chips, micropumps, microneedles, and others. Microfluidics market by application is divided into pharmaceutical research, in vitro diagnostics, and drug delivery. The pharmaceutical research segment is further divided into lab analytics (cell-based assays, proteomic analysis, genomic analysis, and capillary electrophoresis), dispensing, and microreaction. The in vitro diagnostics segment is categorized into clinical diagnostics, point-of-care testing, environmental testing, industrial testing, and agro food testing. On the basis of materials, the microfluidics market is divided into polymer-based microfluidics, glass-based microfluidics, silicon-based microfluidics, and other material-based microfluidics. In addition, country-wise segmentation of each region (North America, Europe, Asia-Pacific, and the Rest of the World) is also provided in the report.

The in vitro diagnostics application segment accounted for a major share of the microfluidics market. This market is primarily driven by the rising demand for point-of-care testing, rising incidences of lifestyle disorders and diseases, growing geriatric population, and rapidly improving healthcare infrastructure in Asian countries.

In 2015, North America accounted for the largest share to the global microfluidics market, followed by Europe, Asia-Pacific, and RoW. However, Asia-Pacific is expected to be the fastest-growing region during the forecast period owing to the rapidly aging population, increased accessibility to healthcare facilities, and rising R&D and healthcare expenditure.

The global microfluidics market is highly fragmented; some of the major players in this market are Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and Becton, Dickinson and Company (U.S.).

Research Coverage:

The report provides a detailed analysis of microfluidics market. It aims at estimating the market size and future growth potential of this market across different segments such as components, application, materials, and regions. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them to garner a greater market share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping a greater market share.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the microfluidics market. The report analyzes the microfluidics market by material and application across all regions
  • Product Development/Innovation: Detailed insights on upcoming trends, research and development activities, and new product launches in the microfluidics market
  • Market Development: Comprehensive information on the lucrative emerging markets by component, material, application, and region
  • Market Diversification: Exhaustive information of new products, growing regions, recent developments, and investments in the microfluidics market
  • Competitive Assessment: In-depth assessment of growth strategies, products, distribution networks, and manufacturing capabilities.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. PERIODIZATION
  • 1.4. CURRENCY AND PRICING
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH APPROACH
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. DATA TRIANGULATION
  • 2.4. KEY DATA FROM SECONDARY SOURCES
  • 2.5. KEY DATA FROM PRIMARY SOURCES
    • 2.5.1. KEY INDUSTRY INSIGHTS
  • 2.6. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. GROWTH POTENTIAL OF THE MICROFLUIDICS MARKET
  • 4.2. ASIA-PACIFIC MICROFLUIDICS MARKET, BY MATERIAL
  • 4.3. MICROFLUIDICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4. NORTH AMERICA IS PROJECTED TO DOMINATE THE MICROFLUIDICS MARKET DURING THE FORECAST PERIOD
  • 4.5. MICROFLUIDICS MARKET: DEVELOPING VS. DEVELOPED COUNTRIES
  • 4.6. MICROFLUIDICS MARKET, BY APPLICATION

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. KEY MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Rising demand for point-of-care (POC) testing
      • 5.2.1.2. Faster returns on investment
      • 5.2.1.3. Faster testing and improved portability through microfluidic chip miniaturization
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Complex and time-consuming regulatory approval process
      • 5.2.2.2. Incorporation of microfluidics technology into existing workflows
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Growing Asian market
      • 5.2.3.2. Expanding applications of drug delivery technologies
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Lack of market visibility for microfluidics products
      • 5.2.4.2. High cost of integrated instruments and microfluidic sensors

6. INDUSTRY INSIGHTS

  • 6.1. INTRODUCTION
  • 6.2. VALUE CHAIN ANALYSIS
  • 6.3. INDUSTRY TRENDS
    • 6.3.1. SHIFTING TREND TOWARD POLYMERS ADOPTION
    • 6.3.2. UNIVERSITIES ACTIVELY GENERATING MICROFLUIDIC START-UPS AND LARGE PLAYERS ACQUIRING SMALL PLAYERS

7. MICROFLUIDICS MARKET, BY COMPONENT

  • 7.1. INTRODUCTION
  • 7.2. MICROFLUIDIC CHIPS
  • 7.3. MICROPUMPS
  • 7.4. MICRONEEDLES
  • 7.5. OTHERS

8. MICROFLUIDICS MARKET, BY MATERIAL

  • 8.1. INTRODUCTION
  • 8.2. POLYMER-BASED MICROFLUIDICS
  • 8.3. GLASS-BASED MICROFLUIDICS
  • 8.4. SILICON-BASED MICROFLUIDICS
  • 8.5. OTHER MATERIAL-BASED MICROFLUIDICS

9. MICROFLUIDICS MARKET, BY APPLICATION

  • 9.1. INTRODUCTION
  • 9.2. IN VITRO DIAGNOSTICS
    • 9.2.1. POINT-OF-CARE TESTING
    • 9.2.2. CLINICAL DIAGNOSTICS
    • 9.2.3. AGRO FOOD TESTING
    • 9.2.4. INDUSTRIAL TESTING
    • 9.2.5. ENVIRONMENTAL TESTING
  • 9.3. PHARMACEUTICAL RESEARCH
    • 9.3.1. LAB ANALYTICS
      • 9.3.1.1. Proteomic analysis
      • 9.3.1.2. Genomic analysis
      • 9.3.1.3. Cell-based assay
      • 9.3.1.4. Capillary electrophoresis
    • 9.3.2. MICRODISPENSING
    • 9.3.3. MICROREACTION
  • 9.4. DRUG DELIVERY

10. GLOBAL MICROFLUIDICS MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
    • 10.2.2. CANADA
  • 10.3. EUROPE
    • 10.3.1. GERMANY
    • 10.3.2. FRANCE
    • 10.3.3. U.K.
    • 10.3.4. ITALY
    • 10.3.5. SPAIN
    • 10.3.6. REST OF EUROPE
  • 10.4. ASIA-PACIFIC
    • 10.4.1. JAPAN
    • 10.4.2. CHINA
    • 10.4.3. INDIA
    • 10.4.4. REST OF ASIA-PACIFIC
  • 10.5. REST OF THE WORLD (ROW)
    • 10.5.1. LATIN AMERICA
    • 10.5.2. MIDDLE EAST & AFRICA

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. COMPETITIVE SITUATIONS AND TRENDS
    • 11.2.1. PRODUCT LAUNCHES
    • 11.2.2. PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
    • 11.2.3. ACQUISITIONS
    • 11.2.4. EXPANSIONS

12. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 12.1. INTRODUCTION
  • 12.2. DANAHER CORPORATION
  • 12.3. THERMO FISHER SCIENTIFIC INC.
  • 12.4. PERKINELMER, INC.
  • 12.5. AGILENT TECHNOLOGIES
  • 12.6. BIO-RAD LABORATORIES, INC.
  • 12.7. BECTON, DICKINSON AND COMPANY
  • 12.8. F. HOFFMANN-LA ROCHE LTD.
  • 12.9. ILLUMINA, INC.
  • 12.10. RAINDANCE TECHNOLOGIES, INC.
  • 12.11. DOLOMITE MICROFLUIDICS

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. INSIGHTS OF INDUSTRY EXPERTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. OTHER DEVELOPMENTS
  • 13.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.5. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.6. AVAILABLE CUSTOMIZATIONS
  • 13.7. RELATED REPORTS
  • 13.8. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: IMPACT ANALYSIS: MARKET DRIVERS
  • TABLE 2: IMPACT ANALYSIS: MARKET RESTRAINTS
  • TABLE 3: IMPACT ANALYSIS: MARKET OPPORTUNITIES
  • TABLE 4: IMPACT ANALYSIS: MARKET CHALLENGES
  • TABLE 5: LIST OF UNIVERSITY STARTUPS IN MICROFLUIDICS MARKET
  • TABLE 6: LIST OF ACQUISITIONS IN THE MICROFLUIDICS MARKET
  • TABLE 7: MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 8: MICROFLUIDIC CHIPS MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 9: MICROPUMPS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 10: MICRONEEDLES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 11: OTHER MICROFLUIDIC COMPONENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 12: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 13: GLOBAL POLYMER-BASED MICROFLUIDICS MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 14: GLOBAL GLASS-BASED MICROFLUIDICS MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 15: GLOBAL SILICON-BASED MICROFLUIDICS MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 16: GLOBAL OTHER MATERIAL-BASED MICROFLUIDICS MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 17: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 18: MICROFLUIDICS MARKET SIZE FORIN VITRO DIAGNOSTICS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 19: MICROFLUIDICS MARKET SIZE FOR IN VITRO DIAGNOSTICS, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 20: MICROFLUIDICS MARKET SIZE FOR POINT-OF-CARE TESTING, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 21: MICROFLUIDICS MARKET SIZE FOR CLINICAL DIAGNOSTICS, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 22: MICROFLUIDICS MARKET SIZE FOR AGRO FOOD TESTING, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 23: MICROFLUIDICS MARKET SIZE FOR INDUSTRIAL TESTING, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 24: MICROFLUIDICS MARKET SIZE FOR ENVIRONMENTAL TESTING, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 25: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 26: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 27: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 28: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 29: MICROFLUIDICS MARKET SIZE FOR PROTEOMIC ANALYSIS, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 30: MICROFLUIDICS MARKET SIZE FOR GENOMIC ANALYSIS, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 31: MICROFLUIDICS MARKET SIZE FOR CELL-BASED ASSAYS, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 32: MICROFLUIDICS MARKET SIZE FOR CAPILLARY ELECTROPHORESIS, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 33: MICROFLUIDICS MARKET SIZE FOR MICRODISPENSING, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 34: MICROFLUIDIC MARKET SIZE FOR MICROREACTION, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 35: MICROFLUIDICS MARKET SIZE FOR DRUG DELIVERY, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 36: NORTH AMERICA: MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 37: NORTH AMERICA: MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 38: NORTH AMERICA: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 39: NORTH AMERICA: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 40: NORTH AMERICA: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 41: NORTH AMERICA: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 42: NORTH AMERICA: MICROFLUIDICS MARKET SIZE FOR IN-VITRO DIAGNOSTICS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 43: U.S.: MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 44: U.S.: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 45: U.S.: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 46: U.S.: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 47: U.S.: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 48: U.S.: MICROFLUIDICS MARKET SIZE FOR IN-VITRO DIAGNOSTICS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 49: CANADA: MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 50: CANADA: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 51: CANADA: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 52: CANADA: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 53: CANADA: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 54: CANADA: MICROFLUIDICS MARKET SIZE FOR IN-VITRO DIAGNOSTICS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 55: EUROPE: MICROFLUIDICS MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 56: EUROPE: MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 57: EUROPE: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 58: EUROPE: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 59: EUROPE: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 60: EUROPE: MICROFLUDICS MARKET SIZE FOR LAB ANALYTICS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 61: EUROPE: MICROFLUDICS MARKET SIZE FOR IN-VITRO DIAGNOSTICS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 62: GERMANY: MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 63: GERMANY: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 64: GERMANY: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 65: GERMANY: MICROFLUDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 66: GERMANY: MICROFLUDICS MARKET SIZE FOR LAB ANALYTICS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 67: GERMANY: MICROFLUDICS MARKET SIZE FOR IN-VITRO DIAGNOSTICS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 68: FRANCE: MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 69: FRANCE: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 70: FRANCE: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 71: FRANCE: MICROFLUDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 72: FRANCE: MICROFLUDICS MARKET SIZE FOR LAB ANALYTICS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 73: FRANCE: MICROFLUDICS MARKET SIZE FOR IN-VITRO DIAGNOSTICS APPLICATION, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 74: U.K.: MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 75: U.K.: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 76: U.K.: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 77: U.K.: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 78: U.K.: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 79: U.K.: MICROFLUIDICS MARKET SIZE FOR IN-VITRO DIAGNOSTICS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 80: ITALY: MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 81: ITALY: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 82: ITALY: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 83: ITALY: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 84: ITALY: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 85: ITALY: MICROFLUIDICS MARKET SIZE FOR IN-VITRO DIAGNOSTICS APPLICATION, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 86: SPAIN: MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 87: SPAIN: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 88: SPAIN: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 89: SPAIN: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 90: SPAIN: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 91: SPAIN: MICROFLUDICS MARKET SIZE FOR IN-VITRO DIAGNOSTICS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 92: ROE: MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 93: ROE: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 94: ROE: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 95: ROE: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 96: ROE: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 97: ROE: MICROFLUDICS MARKET SIZE FOR IN-VITRO DIAGNOSTICS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 98: ASIA-PACIFIC: MICROFLUIDICS MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 99: ASIA-PACIFIC: MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 100: ASIA-PACIFIC: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 101: ASIA-PACIFIC: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 102: ASIA-PACIFIC: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH APPLICATION, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 103: ASIA-PACIFIC: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS APPLICATION, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 104: ASIA-PACIFIC: MICROFLUIDICS MARKET SIZE FOR IN VITRO DIAGNOSTICS APPLICATION, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 105: JAPAN: MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 106: JAPAN: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 107: JAPAN: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 108: JAPAN: MICROFLUDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH APPLICATION, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 109: JAPAN: MICROFLUDICS MARKET SIZE FOR LAB ANALYTICS APPLICATION, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 110: JAPAN: MICROFLUDICS MARKET SIZE FOR IN VITRO DIAGNOSTICS APPLICATION, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 111: CHINA: MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 112: CHINA: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 113: CHINA: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 114: CHINA: MICROFLUDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH APPLICATION, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 115: CHINA: MICROFLUDICS MARKET SIZE FOR LAB ANALYTICS APPLICATION, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 116: CHINA: MICROFLUDICS MARKET SIZE FOR IN VITRO DIAGNOSTICS APPLICATION, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 117: INDIA: MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 118: INDIA: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 119: INDIA: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 120: INDIA: MICROFLUDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH APPLICATION, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 121: INDIA: MICROFLUDICS MARKET SIZE FOR LAB ANALYTICS APPLICATION, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 122: INDIA: MICROFLUDICS MARKET SIZE FOR IN VITRO DIAGNOSTICS APPLICATION, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 123: REST OF ASIA-PACIFIC: MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 124: REST OF ASIA-PACIFIC: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 125: REST OF ASIA-PACIFIC: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 126: REST OF ASIA-PACIFIC: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH APPLICATION, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 127: REST OF ASIA-PACIFIC: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS APPLICATION, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 128: REST OF ASIA-PACIFIC: MICROFLUIDICS MARKET SIZE FOR IN VITRO DIAGNOSTICS APPLICATION, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 129: ROW: MICROFLUIDICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 130: ROW: MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 131: ROW: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 132: ROW: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 133: ROW: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH APPLICATION, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 134: ROW: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS APPLICATION, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 135: ROW: MICROFLUIDICS MARKET SIZE FOR IN VITRO DIAGNOSTICS APPLICATION, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 136: LATIN AMREICA: MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 137: LATIN AMERICA: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 138: LATIN AMERICA: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 139: LATIN AMERICA: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH APPLICATION, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 140: LATIN AMERICA: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS APPLICATION, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 141: LATIN AMERICA: MICROFLUIDICS MARKET SIZE FOR IN VITRO DIAGNOSTICS APPLICATION, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 142: MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 143: MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 144: MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 145: MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH APPLICATION, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 146: MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS APPLICATION, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 147: MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET SIZE FOR IN VITRO DIAGNOSTICS APPLICATION, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 148: GROWTH STRATEGY MATRIX (2013-2016)
  • TABLE 149: PRODUCT LAUNCHES, 2013-2016
  • TABLE 150: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS, 2013-2016
  • TABLE 151: ACQUISITIONS, 2013-2016
  • TABLE 152: EXPANSIONS, 2013-2016

LIST OF FIGURES

  • FIGURE 1: GLOBAL MICROFLUIDICS MARKET SEGMENTATION
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: BOTTOM-UP APPROACH
  • FIGURE 5: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: DRUG DELIVERY TO REGISTER MAXIMUM GROWTH DURING THE FORECAST PERIOD
  • FIGURE 8: POINT-OF-CARE TESTING TO DOMINATE THE GLOBAL MICROFLUIDICS MARKET FOR PHARMACEUTICAL RESEARCH APPLICATION THROUGH 2021
  • FIGURE 9: POLYMER-BASED MICROFLUIDICS ESTIMATED AS THE LARGEST SEGMENT OF THE GLOBAL MICROFLUIDICS MARKET IN 2016
  • FIGURE 10: MICROFLUIDIC CHIPS TO DOMINATE THE MICROFLUIDICS MARKET TILL 2021
  • FIGURE 11: GEOGRAPHIC ANALYSIS: GLOBAL MICROFLUIDICS MARKET
  • FIGURE 12: RISING DEMAND FOR POINT-OF-CARE TESTING IS DRIVING THE GROWTH OF THE GLOBAL MICROFLUIDICS MARKET
  • FIGURE 13: JAPAN ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA-PACIFIC MICROFLUIDICS MARKET, BY MATERIAL, IN 2015
  • FIGURE 14: THE U.S. ACCOUNTED FOR THE LARGEST SHARE OF THE GLOBAL MICROFLUIDICS MARKET IN 2015
  • FIGURE 15: MICROFLUIDICS MARKET: GEOGRAPHIC MIX, 2014-2021 (USD BILLION)
  • FIGURE 16: CHINA IS PROJECTED TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 17: IN VITRO DIAGNOSTICS IS EXPECTED TO DOMINATE THE MICROFLUIDICS MARKET THROUGH 2021
  • FIGURE 18: MICROFLUIDICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 19: VALUE CHAIN ANALYSIS
  • FIGURE 20: MICROFLUIDICS MARKET PLAYERS SHIFTING TOWARD POLYMERS ADOPTION
  • FIGURE 21: MICROFLUIDIC CHIPS SEGMENT TO DOMINATE THE MICROFLUIDICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 22: POLYMER-BASED MICROFLUIDICS TO REGISTER MAXIMUM GROWTH DURING THE FORECAST PERIOD
  • FIGURE 23: MICROFLUDICS MARKET SIZE, BY APPLICATION, 2016 VS. 2021 (USD MILLION)
  • FIGURE 24: POINT-OF-CARE TESTING SEGMENT TO COMMAND THE LARGEST SHARE OF THE IN VITRO DIAGNOSTICS MARKET IN 2016
  • FIGURE 25: LAB ANALYTICS TO ACCOUNT FOR THE LARGEST SHARE IN THE GLOBAL MARKET FOR MICROFLUIDICS IN PHARMACEUTICAL RESEARCH IN 2016
  • FIGURE 26: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS, BY TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 27: MICROFLUIDICS MARKET: GEOGRAPHIC SNAPSHOT (2016)
  • FIGURE 28: NORTH AMERICA: MICROFLUIDICS MARKET SNAPSHOT
  • FIGURE 29: ASIA-PACIFIC: MICROFLUIDICS MARKET SNAPSHOT
  • FIGURE 30: PRODUCT LAUNCHES WAS THE KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS (2013 TO 2016)
  • FIGURE 31: BATTLE FOR DEVELOPMENTAL MARKET SHARE: NEW PRODUCT LAUNCHES ACCOUNTED FOR THE LARGEST SHARE
  • FIGURE 32: COMPARATIVE ASSESSMENT OF KEY PLAYERS IN THE MICROFLUIDICS MARKET (2013-2016)
  • FIGURE 33: GEOGRAPHIC REVENUE MIX OF TOP PLAYERS
  • FIGURE 34: COMPANY SNAPSHOT: DANAHER CORPORATION
  • FIGURE 35: COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC INC.
  • FIGURE 36: PERKINELMER INC.: COMPANY SNAPSHOT
  • FIGURE 37: AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
  • FIGURE 38: COMPANY SNAPSHOT: BIO-RAD LABORATORIES, INC.
  • FIGURE 39: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • FIGURE 40: F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
  • FIGURE 41: ILLUMINA, INC.: COMPANY SNAPSHOT
Back to Top